Insider Transactions in Q4 2021 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,597
-3.85%
|
$193,567
$11.55 P/Share
|
Dec 31
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,502
-3.61%
|
$115,522
$11.55 P/Share
|
Dec 31
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,483
-3.93%
|
$104,313
$11.55 P/Share
|
Dec 31
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
31,479
-3.82%
|
$346,269
$11.55 P/Share
|
Dec 31
2021
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,280
-4.31%
|
$80,080
$11.55 P/Share
|
Dec 22
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.65%
|
$33,000
$11.7 P/Share
|
Dec 22
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.65%
|
$12,000
$4.38 P/Share
|
Dec 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,515
-2.25%
|
$115,665
$11.0 P/Share
|
Dec 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,515
+2.2%
|
$42,060
$4.38 P/Share
|
Nov 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
24,935
-2.94%
|
$274,285
$11.75 P/Share
|
Nov 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
24,935
+2.85%
|
$99,740
$4.38 P/Share
|
Nov 03
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
27,739
-3.25%
|
$332,868
$12.0 P/Share
|
Nov 03
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
27,739
+3.15%
|
$83,217
$3.82 P/Share
|
Nov 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,515
-2.25%
|
$115,665
$11.32 P/Share
|
Nov 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,515
+2.2%
|
$42,060
$4.38 P/Share
|
Nov 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,819
-0.94%
|
$78,190
$10.8 P/Share
|
Nov 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+2.25%
|
$15,000
$10.49 P/Share
|
Oct 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.58%
|
$242,000
$11.22 P/Share
|
Oct 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.51%
|
$88,000
$4.38 P/Share
|
Oct 09
2021
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,510
-3.16%
|
$60,610
$11.51 P/Share
|
Oct 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,515
-2.25%
|
$105,150
$10.0 P/Share
|
Oct 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,515
+2.2%
|
$42,060
$4.38 P/Share
|
Oct 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.89%
|
$75,000
$10.0 P/Share
|
Oct 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+2.3%
|
$13,500
$9.56 P/Share
|